Switzerland· 45866001
Phosphonorm, Hartkapseln
A aluminium chlorohydrate product, registered in Switzerland by Salmon Pharma GmbH and dispensed under Swissmedic category B.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Manufacturer
- Salmon Pharma GmbH
- Country
- Switzerland (CH)
- ATC code
- M05BX02
- ATC class
- Aluminium chlorohydrate
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
13 interactions on record for aluminium chlorohydrate.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aluminium chlorohydrate · interactions on record
13 records
13 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under M05BX02
Aluminium chlorohydrate, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/44580e58-28b9-4d30-807d-02639da6f9fe GET /v1/drugs/44580e58-28b9-4d30-807d-02639da6f9fe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about aluminium chlorohydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.